baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out PHARM/ DE000SJ045N8 /

2024-11-12 9:19:15 AM	Chg.-0.016	Bid10:00:38 PM	Ask10:00:38 PM	Underlying	Strike price	Expiration date	Option type
0.062EUR	-20.51%	- Bid Size: -	- Ask Size: -	Pharming Group	0.6847 EUR	2078-12-31	Call

GlobeNewswire 08-01 Pharming Group reports second quarter and first half 2024 financial results and provides business up...

GlobeNewswire 07-18 Pharming Group to report second quarter and first half 2024 financial results on August 1

GlobeNewswire 06-03 Pharming Group to participate in June investor conferences

GlobeNewswire 05-21 Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

GlobeNewswire 05-20 Pharming Group to participate in May investor conference

GlobeNewswire 05-08 Pharming Group reports first quarter 2024 financial results and provides business update

GlobeNewswire 04-24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...

GlobeNewswire 04-08 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

GlobeNewswire 04-03 Pharming Group to participate in April investor conferences

GlobeNewswire 03-14 Pharming Group reports fourth quarter and full year 2023 financial results

GlobeNewswire 02-29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14

GlobeNewswire 02-08 Pharming Group to participate in February investor conferences

GlobeNewswire 01-08 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update

GlobeNewswire 2023-12-13 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...

GlobeNewswire 2023-11-21 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...

GlobeNewswire 2023-11-13 Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...

GlobeNewswire 2023-11-01 Pharming Group to participate in November investor conferences

GlobeNewswire 2023-10-26 Pharming Group reports third quarter 2023 financial results

GlobeNewswire 2023-10-12 Pharming Group to report third quarter 2023 financial results on October 26

GlobeNewswire 2023-09-25 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

GlobeNewswire 2022-01-10 Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene The...

GlobeNewswire 2021-11-04 Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Upd...

GlobeNewswire 2021-08-04 Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Up...

GlobeNewswire 2021-07-29 Oncorus Expands its Board with Appointment of Barbara Yanni

GlobeNewswire 2021-07-01 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo ...

Soc. Generale Knock-Out PHARM/ DE000SJ045N8 /

If you wish to receive reply to your feedback, please provide your email address.